HaroldSuperkoMDFACC, FAHA, FAACVPR, FACSM

Summary

• Dr. Superko’s education includes the University of California, San Diego, State University of New York Stony Brook (MD), and the University of California, Davis (Internship, Residency, Fellowship).
  Following his professional training he served as Director of the Stanford University Lipid Research Clinic and Laboratory (LRC-CPPT) from 1981 to 1990, Director of the University of California, Berkeley, Cholesterol Research Center at the Lawrence Berkeley National Laboratory from 1990 to 2000, Director of Research at Berkeley HeartLab from 2000 to 2004, and Chairman of Molecular and Genetic Cardiology at the Fuqua Heart Center and Saint Joseph’s Hospital in Atlanta, Georgia from 2004 to 2009. His most recent position was as Chief Medical Officer at Celera Corporation in Alameda, California and affiliated with the Mercer University School of Pharmaceutical Sciences. He is Chairman of the non-profit Cholesterol, Genetics, and Heart Disease Institute.
  
  Dr Superko has participated in numerous CME programs and committees as a Fellow of the American College of Cardiology and the American Heart Association. He was Director of the American Heart Association Lipid Disorders Training Center in California and Chairman of several National CME programs. He has received many awards and honors, most recently the Larry King Cardiac Foundation Physician Laureate award for lifetime efforts in preventive cardiology.
  
  His research interests have included the role of lipoproteins and genetics in the atherosclerotic process and the need to think beyond standard risk factors. He was among the first to publish articles revealing the lack of clinical event benefit in statin trials. He has participated primarily in federal research trials involving lipoprotein subclasses, randomized NIH funded trial of caffeinated vs decaffeinated coffee drinking, arteriographic regression trials, diet modification trials, weight loss trials, family heart disease studies, genetic studies, and most